Body composition changes after laparoscopic adjustable gastric banding: What is the role of 174G>C interleukin-6 promoter gene polymorphism in the therapeutic strategy

International Journal of Obesity

Volumn 36, Issue 3, 2012, Pages 369-378

  Di Renzo, L ^a,b   Carbonelli, M G ^c   Bianchi, A ^a   Iacopino, L ^a   Fiorito, R ^a   Di Daniele, N ^a   De Lorenzo, A ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b INDiM   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

174G4>C IL 6 polymorphism; body composition; laparoscopic adjustable gastric banding

Indexed keywords

INTERLEUKIN 6;

ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WATER; BONE DENSITY; CLINICAL ARTICLE; FEMALE; GASTRIC BANDING; HOMEOSTASIS; HUMAN; LABORATORY TEST; MALE; METABOLIC RATE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT REDUCTION;

ADULT; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HUMANS; INTERLEUKIN-6; ITALY; LAPAROSCOPY; MALE; OBESITY, MORBID; PATIENT SELECTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; QUESTIONNAIRES; WEIGHT LOSS;

EID: 84858290113     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2011.132     Document Type: Article

References (62)

1. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200. (Pubitemid 27525539)
2. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338-3342.
3. Sopasakis VR, Sandqvist M, Gustafson B, Hammarstedt A, Schmelz M, Yang X et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 2004; 12: 454-460. (Pubitemid 41132524)
4. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282. (Pubitemid 38535056)
5. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847-850. (Pubitemid 28496456)
6. Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson SL et al. Interleukin-6-deficient mice develop matureonset obesity. Nat Med 2002; 8: 75-79. (Pubitemid 34101732)
7. Wallenius K, Wallenius VW, Sunter D, Dickson SL, Jansson J-O. Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Comm 2002; 293: 560-565. (Pubitemid 34694245)
8. Li G, Klein RL, Matheny M, King MA, Meyer EM, Scarpace PJ. Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue, underlies one mechanism of body weight reduction in rats. Neuroscience 2002; 115: 879-889. (Pubitemid 35336030)
9. Hirano T. Interleukin 6, its receptor: ten years later. Int Rev Immunol 1998; 16: 249-284. (Pubitemid 28102256)
10. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-355. (Pubitemid 40277057)
11. Di Renzo L, Galvano F, Orlandi C, Bianchi A, Di Giacomo C, La Fauci L et al. Oxidative Stress in normal-weight obese syndrome. Obesity (Silver Spring) 2010; 18: 2401.
12. De Lorenzo A, Deurenberg P, Pietrantuono M, Di Daniele N, Cervelli V, Andreoli A. How fat is obese? Acta Diabetol 2003; 40: S254-S257. (Pubitemid 37322768)
13. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L. Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis 2006; 16: 513-523. (Pubitemid 44794584)
14. De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L. Normal-weight obese syndrome: early inflammation? Am J Clin Nutr 2007; 85: 40-45. (Pubitemid 46067613)
15. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376. (Pubitemid 28467565)
16. Wernstedt I, Eriksson AL, Berndtsson A, Hoffstedt J, Skrtic S, Hedner T et al. A common polymorphism in the interleukin-6 gene promoter is associated with overweight. Int J Obes Relat Metab Disord 2004; 28: 1272-1279. (Pubitemid 39389584)
17. Berthier MT, Paradis AM, Tchernof A, Bergeron J, Prud'homme D, Després JP et al. The interleukin 6-174G/C polymorphism is associated with indices of obesity in men. J Hum Genet 2003; 48: 14-19. (Pubitemid 36205641)
18. Strandberg L, Mellström D, Ljunggren O, Grundberg E, Karlsson MK, Holmberg AH et al. IL6 and IL1B polymorphisms are associated with fat mass in older men: the MrOS Study Sweden. Obesity (Silver Spring) 2008; 16: 710-713. (Pubitemid 351328025)
19. Poitou C, Lacorte JM, Coupaye M, Bertrais S, Bedel JF, Lafon N et al. Relationship between single nucleotide polymorphisms in leptin, IL6 and adiponectin genes and their circulating product in morbidly obese subjects before and after gastric banding surgery. Obes Surg 2005; 15: 11-23. (Pubitemid 40203820)
20. Lubrano C, Mariani S, Badiali M, Cuzzolaro M, Barbaro G, Migliaccio S et al. Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes (Lond) 2010; 34: 1404-1414.
21. Sesti G, Perego L, Cardellini M, Andreozzi F, Ricasoli C, Vedani P et al. Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. J Clin Endocrinol Metab 2005; 90: 5064-5069. (Pubitemid 41262255)
22. Erratum in: J Clin Endocrinol Metab 2005; 90(10): 5810.
23. Anonymous. 1995 Physical status: the use and interpretation of anthropometry: report of a WHO expert committee. WHO Tech Rep Ser 854: 1-452.
24. Consensus Development Conference Panel. NIH conference. Gastrointestinal surgery for severe obesity. Intern Ann Med 1991; 115: 956-961.
25. Marcus MD, Kalarchian MA. Courcoulas AP psychiatric evaluation follow-up of bariatric surgery patients. Am J Psychiatry 2009; 166: 285-291.
26. Lo Coco G, Gullo S, Salerno L, Iacoponelli R. The association among interpersonal problems, binge behaviors, and self-esteem, in the assessment of obese individuals. Compr Psychiatry 2011; 52: 164-170.
27. Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr 2005; 82: 1074-1081. (Pubitemid 43779767)
28. Gortmaker SL, Peterson K, Wiecha J, Sobol AM, Dixit S, Fox MK et al. Reducing obesity via a school-based interdisciplinary intervention among youth: planet health. Arch Pediatr Adolesc Med 1999; 153: 409-418. (Pubitemid 29160029)
29. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual 1998. Human Kinetics: Champaign, IL.
30. Di Renzo L, Del Gobbo V, Bigioni M, Premrov MG, Cianci R, De Lorenzo A. Body composition analyses in normal weight obese women. Eur Rev Med Pharmacol Sci 2006; 10: 191-196. (Pubitemid 44468945)
31. De Lorenzo A, Candeloro N, Andreoli A, Durenberg P. Determination of intracellular water by multifrequency bioelectrical impedance. Ann Nutr Metab 1995; 39: 177-184.
32. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949; 109: 1-9.
33. International Diabetes Federation (IDF). The IDF Consensus Worldwide Definition of the Metabolic Syndrome 2006. International Diabetes Federation: Brussels, Belgium.
34. World Health Organization (WHO). Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF Consultation. WHO Library Cataloguing-in-Publication Data, 2006.
35. Di Renzo L, Bertoli A, Bigioni M, Del Gobbo V, Premrov MG, Calabrese V et al. Body composition and 174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Curr Pharm Des 2008; 14: 2699-2706.
36. Coupaye M, Bouillot JL, Coussieu C, Guy-Grand B, Basdevant A, Oppert JM. One-year changes in energy expenditure and serum leptin following adjustable silicone gastric banding in obese women. Obes Surg 2005; 15: 827-833. (Pubitemid 40904874)
37. Sergi G, Lupoli L, Busetto L. Changes in fluid compartments and body composition in obese women after weight loss induced by gastric banding. Ann Nutr Metab 2003; 47: 152-157. (Pubitemid 36578807)
38. Coupaye M, Bouillot JL, Poitou C, Schutz Y, Basdevant A, Oppert JM. Is lean body mass decreased after obesity treatment by adjustable gastric banding? Obes Surg 2007; 17: 427-433. (Pubitemid 46850176)
39. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and metaanalysis. JAMA 2004; 292: 1724-1737 (review). (Pubitemid 39346675)
40. Erratum in JAMA 2005; 293(14): 1728.
41. Giusti V, Suter M, Héräef E, Gaillard RC, Burckhardt P. Effects of laparoscopic gastric banding on body composition, metabolic profile and nutritional status of obese women: 12-months followup. Obes Surg 2004; 14: 239-245. (Pubitemid 38281099)
42. Gasteyger C, Suter M, Calmes JM, Gaillard RC, Giusti V. Changes in body composition, metabolic profile and nutritional status 24 months after gastric banding. Obes Surg 2006; 16: 243-250.
43. Andreoli A, Melchiorri G, De Lorenzo A, Caruso I, Sinibaldi Salimei P, Guerrisi M. Bioelectrical impedance measures in different position and vs dual-energy X-ray absorptiometry (DXA). J Sports Med Phys Fitness 2002; 42: 186-189. (Pubitemid 34733697)
44. Benedetti G, Mingrone G, Marcoccia S, Benedetti M, Giancaterini A, Greco AV et al. Body composition and energy expenditure after weight loss,following bariatric surgery. J Am Coll Nutr 2000; 19: 270-274. (Pubitemid 30185360)
45. Infanger D, Baldinger R, Branson R, Barbier T, Steffen R, Horber FF. Effect of significant intermediate-term weight loss on serum leptin levels and body composition in severely obese subjects. Obes Surg 2003; 13: 879-888. (Pubitemid 38010709)
46. Matthie J, Zarowitz B, De Lorenzo A, Andreoli A, Katzarski K, Pan G et al. Analytic assessment of the various bioimpedance methods used to estimate body water. J Appl Physiol 1998; 84: 1801-1816. (Pubitemid 28225924)
47. Savastano S, Belfiore A, Di Somma C, Mauriello C, Rossi A, Pizza G et al. Validity of bioelectrical impedance analysis to estimate body composition changes after bariatric surgery in premenopausal morbidly women. Obes Surg 2010; 20: 332-339.
48. Stephens JW, Hurel SJ, Cooper JA, Acharya J, Miller GJ, Humphries SE. A common functional variant in the interleukin-gene is associated with increased body mass index in subjects with type 2 diabetes mellitus. Mol Genet Metab 2004; 82: 180-186. (Pubitemid 38692557)
49. Klipstein-Grobusch K, Möhlig M, Spranger J, HoLMann K, Rodrigues FU, Sharma AM et al. Interleukin-6 g.-174G°C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study. Obes Res 2006; 14: 14-18. (Pubitemid 46214770)
50. Grallert H, Huth C, Kolz M, Meisinger C, Herder C, Strassburger K et al. IL-6 promoter polymorphisms and quantitative traits related to themetabolic syndrome in KORA S4. Exp Gerontol 2006; 41: 737-745. (Pubitemid 44223893)
51. Qi L, Zhang C, van Dam RM, Hu FB. Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26 944 individuals. J Clin Endocrinol Metab 2007; 92: 3618-3625. (Pubitemid 47435347)
52. Huth C, Illig T, Herder C, Gieger C, Grallert H, Vollmert C et al. Joint analysis of individual participants0 data from 17 studies on the association of the IL6 variant 174G4C with circulating glucose levels, interleukin-6 levels, and body mass index. Ann Med 2009; 41: 128-138.
53. Vozarova B, Fernandez-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD et al. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet 2003; 112: 409-413. (Pubitemid 36869070)
54. Mohlig M, Boeing H, Spranger J, Osterhoff M, Kroke A, Fisher E et al. Body mass index and C-174G interleukin-6 promoter polymorphism interact in predicting type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 1885-1890. (Pubitemid 38507949)
55. Fernandez-Real JM, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M et al. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 2000; 49: 517-520. (Pubitemid 30131802)
56. Hamid YH, Rose CS, Urhammer SA, Glumer C, Nolsoe R, Kristiansen OP et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 2005; 48: 251-260. (Pubitemid 40543296)
57. Bonaf M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol 2001; 31: 2357-2361. (Pubitemid 32785354)
58. Riikola A, Sipilä K, Kähönen M, Jula A, Nieminen MS, Moilanen L et al. Interleukin-6 promoter polymorphism and cardiovascular risk factors: the Health 2000 Survey. Atherosclerosis 2009; 207: 466-470.
59. Moleres A, Rendo-Urteaga T, Azcona C, Martínez JA, Gómez-Martínez S, Ruiz JR et al. Il6 gene promoter polymorphism (-174G/C) influences the association between fat mass and cardiovascular risk factors. J Physiol Biochem 2009; 65: 405-413.
60. Eder K, Baffy N, Falus A, Fulop AK. The major inflammatory mediator interleukin-6 and obesity. Inflamm Res 2009; 58: 727-736 (review).
61. Yang X, Jansson PA, Pellmé F, Laakso M, Smith U. Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity. Obes Res 2005; 13: 813-817.
62. Kubaszek A, Pihlajamaki J, Punnonen K, Karhapaa P, Vauhkonen I, Laakso M. The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 2003; 52: 558-561. (Pubitemid 36173216)